Problems of Germline Therapy
By Anne McLaren and Jonathan Ewbank,
Nature
| 04. 16. 1998
Vol. 392, April 16, 1998
Sir-You recently published a full-page
report of a Californian symposium on germline gene therapy,
and a leading article, without a single mention of preimplantation
genetic diagnosis.
If a couple are at risk of having a child with a serious genetic
disease, it is now possible for them to have their embryos screened
at the eight-cell stage, after in vitro fertilization, to ensure
that only unaffected embryos are transferred to the uterus.
Only in the very rare cases where both partners are sufferers
from a recessive condition that allows survival to reproductive
age, such as cystic fibrosis, will no unaffected embryos be
generated. As 10-20 embryos could be produced from a single
egg recovery, it would not be difficult also to avoid the birth
of carriers if that was desired.
Most couples would surely prefer to avoid the transfer of
affected embryos, rather than seeking to tamper with their DNA
at such an early stage, with possibly unpredictable consequences.
Leroy Hood, chair of molecular biotechnology at the University
of Washington, said: "We are using exactly the...
Related Articles
By Abby McCloskey, The Dallas Morning News | 10.10.2025
We Texans like to do things our way — leave some hide on the fence rather than stay corralled, as goes a line in Wallace O. Chariton’s Texas dictionary This Dog’ll Hunt. Lately, I’ve been wondering what this ethos...
By Jay S. Kaufman, Los Angeles Review of Books | 09.27.2025
This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...